Category: Disclosures

[Disclosure] Samsung Biologics (207940) – Provisional Operating Performance (Fair Disclosure) / 2025-10-28

October 28, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has disclosed its Q3 2025 consolidated provisional financial results, reporting revenue of KRW 1,660.2B (+39.86% YoY), operating profit of KRW 728.8B (+115.27% YoY), and net profit of KRW 574.5B (+117.21% YoY). 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint)…

Disclosures, Bio & Healthcare

[Disclosure] Celltrion (068270) – Application for Modification of Phase 3 Clinical Trial Plan in Europe for CT-P55 (Cosentyx Biosimilar) (Part 1 & 2) / 2025-10-27

October 27, 2025August 6, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Celltrion has submitted an application to the European Medicines Agency (EMA) to modify the Phase 3 clinical trial plan (Part 1 & 2) for ‘CT-P55’, a biosimilar to Cosentyx, following adjustments to its regulatory strategy and patient sample size. 📊 [Key Disclosure Details & Financial Summary]…

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Ocean (042660) – Consolidated Preliminary Financial Results / 2025-10-27

October 27, 2025August 8, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hanwha Ocean reported Q3 2025 consolidated operating profit of KRW 289.8B (up 1,032.0% YoY), revenue of KRW 3.0234T (up 11.8% YoY), and net profit of KRW 269.4B, turning back to profitability compared to Q3 2024. 📊 [Key Disclosure Details & Financial Summary] 1. Q3 2025 Financial…

Disclosures, Shipbuilding

[Disclosure] Hanwha Aerospace (012450) – Execution of Single Sales or Supply Contract / 2025-10-27

October 27, 2025August 9, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hanwha Aerospace signed a manufacturing contract with LIG Nex1 Co., Ltd. for the launcher division of the IM3 project, valued at approximately KRW 388.18B (3.45% of 2024 annual sales). 📊 [Key Disclosure Contents & Summary of Figures] [Contract Details & Scale] [Counterparty & Terms] [Other Key…

Disclosures, Defense

[Disclosure] Hanwha Systems (272210) – Sales / Supply Contract / 2025-10-27

October 27, 2025August 11, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems has signed a major supply contract worth approximately KRW 859.3B with LIG Nex1 for the mass production of multi-function radars for the Cheongung-II export project to Iraq (IM3 project). This represents 30.65% of its 2024 consolidated revenue. 📊 [Key Disclosure Details & Financial Highlights]…

Disclosures, Defense

[Disclosure] Jusung Engineering (036930) – Consolidated Financial Results (Provisional) / 2025-10-27

October 27, 2025August 3, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Jusung Engineering reported Q3 2025 consolidated revenue of KRW 58.8B (-25.4% QoQ) and operating profit of KRW 3.4B (-49.0% QoQ), while net profit rose 48.5% QoQ to KRW 7.5B. 📊 [Key Disclosure Contents & Summary Metrics] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Final…

Semiconductors, Disclosures

[Disclosure] Daeduck Electronics (353200) – Advance Notice of Earnings Release / 2025-10-24

October 24, 2025August 3, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Daeduck Electronics announced that it plans to release its financial results for Q3 2025 (July 1, 2025 ~ September 30, 2025) on November 4, 2025. 📊 Key Disclosure Contents & Major Figures 1. Advance Notice Overview 2. Other Reference Details & Material Release Plan 📝 Editor’s…

Semiconductors, Disclosures

[Disclosure] Daeduck Electronics (353200) – Invitation to Investor Relations (IR) / 2025-10-24

October 24, 2025August 3, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Daeduck Electronics announced that it will host Non-Deal Roadshow (NDR) investor relations meetings for domestic institutional investors for 3 days starting November 5, 2025, to explain its Q3 2025 business results and outlook. 📊 Key Disclosure Contents & Major Figures 1. Investor Relations (IR) Event Overview…

Semiconductors, Disclosures

[Disclosure] Samsung Biologics (207940) – Information Disclosure / 2025-10-23

October 23, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has announced the suspension of trading for its common stock and related stock futures/options starting October 30, 2025, until the listing change date, due to electronic registration changes and cancellations stemming from a corporate spin-off. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s…

Disclosures, Bio & Healthcare

[Disclosure] Samsung Biologics (207940) – Information Disclosure / 2025-10-23

October 23, 2025August 7, 2026 K-STOCK Editor

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Following market measures applied to the underlying equity, Samsung Biologics has announced that trading of its stock futures and stock options will be suspended starting October 30, 2025. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verifying Trading Suspension Enforcement…

Disclosures, Bio & Healthcare